HCRN-LUN21-534

DURABLE: Delayed or Upfront brain RAdiotherapy in treatment naïve lung cancer patients with asymptomatic or minimally symptomatic Brain metastases and rEarrangements

Status

Currently Enrolling

Cancer Type(s)

Trial Locations

All sites in which the trial HCRN-LUN21-534 being conducted in.